Bank of America
AYLA

Bank of America’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Bank of America’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,940
Closed -$17K – 9029
2021
Q4 		$17K Buy
+1,940
New +$19.2K ﹤0.01% 7573

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Bank of America's AYLA Position: Q1 2022 in Review

Bank of America sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2022, closing a stake of 1,940 shares — an estimated $17K sold.

Bank of America first reported a position in AYLA in Q4 2021 and held it in 1 quarter. The position peaked at $17K in Q4 2021. 14 funds tracked by Wall St. Rank hold AYLA as of Q1 2022.

  • Bank of America reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 1,940 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $17K.
  • Bank of America first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Bank of America's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $17K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.